Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis

Abstract

Thirty children with medulloblastoma who were treated between 1980 and 1986 are presented. Flow cytometric DNA analysis using formalin-fixed and paraffin-embedded tissues showed that 15 were DNA aneuploid, 13 diploid and 2 tetraploid. After homogeneous treatment with a combination of radical resection and radiation therapy, patients with DNA aneuploid medulloblastoma showed significantly better outcome (p = 0.003). Among these 30 patients, 6 (20%) had bone metastases of medulloblastoma during a minimum of 2-year follow-up period. DNA ploidy of these patients was diploid in 5 and aneuploid in 1. Incidence of bone metastases appears to correlate with DNA ploidy (p = 0.046). At the time of discovery of bone metastases, 4 had no demonstrable recurrence in the central nervous system (CNS). Radionuclide bone scan was more sensitive in disclosing these lesions, while only one patient had positive results of bone marrow aspirates/biopsy. Three patients were treated with chemotherapy, two had a combination of regional irradiation and chemotherapy and one refused treatment. All treated bone metastases in 5 patients responded clinically and radiographically, but only one patient is alive 66 months after therapy. Four patients died due to either CNS recurrence of septic complication of chemotherapy. Early detection of bone metastases by use of frequent bone scans is important. Patients with diploid medulloblastoma should be treated with adjuvant chemotherapy in order to prevent recurrences and metastases.

Bone morphogenetic proteins-2 and -4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line

“…Unfortunately, this success has also yielded an increased number of recurrent and metastatic CNS lesions that are often resistant to radiotherapy and multiple chemotherapeutic agents (Allen et al, 1996;Chou et al, 1995;Patrice et al, 1995). Extraneural metastases pose an additional challenge in the treatment of PNET-MB (Berger et al, 1991;Brutschin and Culver, 1973;Campbell et al, 1984;Duffner and Cohen, 1981;Hoffman and Duffner, 1985;Tomita et al, 1990;Vieco et al, 1989). Notably, the Fig.…”

111In-Pentetreotide scintigraphy in medulloblastoma: A comparison with magnetic resonance imaging

“…Although MB is easily localized by CT, MRI allows a more sensitive detection of the primary tumour and its relationship to adjacent CNS structures [10]. In MB patients, the following nuclear medicine procedures are performed: bone scan [11]; 99m Tc-HMPAO or 99m Tc ÁECD in neurological complications like mutism [12,13]; 111 In-DTPA for the proof of cerebro-spinal fluid (CSF) flow [14]; 123 I-MIBG [15], 201 Tl [16,17],…”

Features of proliferation and in vitro drug resistance in central primitive neuro‐ectodermal tumours

“…In studies on DNA ploidy in central PNET diploid tumours tend to have a worse prognosis in comparison to aneuploid tumours [37,42].…”